Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) Stock Overview
Explore Bionano Genomics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.9M
P/E Ratio
-0.25
EPS (TTM)
$-4.85
ROE
-0.56%
BNGO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bionano Genomics, Inc. (BNGO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.25 and a market capitalization of 3.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.